Literature DB >> 11092532

Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase.

D Hochberg1, C W Johnson, J Chen, D Cohen, J Stern, E D Vaughan, D Poppas, D Felsen.   

Abstract

Unilateral ureteral obstruction (UUO) is characterized by decreases in renal function and increases in interstitial fibrosis. Previous studies have indicated that pharmacologic manipulations that increase nitric oxide (NO) are beneficial to the obstructed kidneys. NO is produced from arginine by nitric oxide synthase (NOS), an enzyme that exists in both constitutive and inducible (iNOS) forms. To determine the role of the inducible form of NOS in UUO, we used mice with a targeted deletion of iNOS (iNOS -/- mice) and compared them with wild-type (WT) mice. Kidneys were obstructed for 2 weeks in both WT and iNOS -/- mice, and were then removed and bisected. Half of the kidney was embedded in paraffin and tissue sections were examined for interstitial volume or the presence of macrophages. The remainder was flash-frozen and samples were used to measure tissue collagen (hydroxyproline) or transforming growth factor-beta (TGF-beta). This study demonstrates that both cortex and medulla of obstructed kidneys of iNOS -/- mice exhibit significantly increased interstitial volume and interstitial macrophages as compared with their WT counterparts. Furthermore tissue collagen was increased to 9.2+/-1.3 microg/mg tissue in WT obstructed kidneys, whereas in iNOS -/- kidneys, collagen was increased to 13.2+/-0.8 microg/mg tissue. The profibrotic cytokine TGF-beta was also significantly increased in obstructed kidneys of iNOS -/- mice, as compared with WT mice. No differences were noted between the unobstructed kidneys of iNOS -/- mice compared with WT mice in any of the parameters examined. These results demonstrate that targeted deletion of the iNOS results in exacerbation of fibrotic events in the obstructed kidney. These results confirm previous pharmacologic studies, and suggest that NO produced via the inducible NOS normally serves a protective function in UUO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092532     DOI: 10.1038/labinvest.3780182

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Heat shock protein 70/nitric oxide effect on stretched tubular epithelial cells linked to WT-1 cytoprotection during neonatal obstructive nephropathy.

Authors:  Luciana Mazzei; Fernando Darío Cuello-Carrión; Neil Docherty; Walter Manucha
Journal:  Int Urol Nephrol       Date:  2017-07-15       Impact factor: 2.370

2.  Nitric oxide is an important mediator of renal tubular epithelial cell death in vitro and in murine experimental hydronephrosis.

Authors:  Tiina Kipari; Jean-Francois Cailhier; David Ferenbach; Simon Watson; Kris Houlberg; David Walbaum; Spike Clay; John Savill; Jeremy Hughes
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 3.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

4.  Inducible nitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse.

Authors:  Kee Hwan Yoo; Barbara A Thornhill; Michael S Forbes; Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-04

5.  Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Jason R Mock; Yoshiki Eto; Brian T Garibaldi; Daniel C Files; Claudia R Avalos; Jackie V Rodriguez; Adam T Waickman; Sekhar P Reddy; David B Pearse; Venkataramana K Sidhaye; Paul M Hassoun; Michael T Crow; Landon S King
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

6.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

Review 7.  Liposome-mediated gene therapy in the kidney.

Authors:  Keiichi Ito; Jie Chen; Tomohiko Asano; E Darracott Vaughan; Dix P Poppas; Masamichi Hayakawa; Diane Felsen
Journal:  Hum Cell       Date:  2004-03       Impact factor: 4.174

8.  Effect of L-arginine and L-NAME on Kidney Tissue Damage in Rats after 24 h of Bilateral Ureteral Obstruction.

Authors:  Shahnaz Amani Tirani; Zahra Pezeshki; Mehdi Nematbakhsh; Hamid Nasri; Ardeshir Talebi
Journal:  Int J Prev Med       Date:  2015-07-08

Review 9.  Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease.

Authors:  Ana Cristina Simões e Silva; Flávia Cordeiro Valério; Mariana Affonso Vasconcelos; Débora Marques Miranda; Eduardo Araújo Oliveira
Journal:  Clin Dev Immunol       Date:  2013-08-26

Review 10.  Obstructive renal injury: from fluid mechanics to molecular cell biology.

Authors:  Alvaro C Ucero; Sara Gonçalves; Alberto Benito-Martin; Beatriz Santamaría; Adrian M Ramos; Sergio Berzal; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Open Access J Urol       Date:  2010-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.